These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 8428079)
21. Diagnostic value of gadobutrol versus gadopentetate dimeglumine in enhanced MRI of brain metastases. Fan B; Li M; Wang X; Xu Y; Li F; Zhang L; Jiang J; Jiang Y J Magn Reson Imaging; 2017 Jun; 45(6):1827-1834. PubMed ID: 27696616 [TBL] [Abstract][Full Text] [Related]
22. MR imaging characterization of postischemic myocardial dysfunction ("stunned myocardium"): relationship between functional and perfusion abnormalities. Szolar DH; Saeed M; Wendland MF; Sakuma H; Roberts TP; Stiskal MA; Derugin N; Higgins CB J Magn Reson Imaging; 1996; 6(4):615-24. PubMed ID: 8835955 [TBL] [Abstract][Full Text] [Related]
23. Spleen: dynamic enhancement patterns on gradient-echo MR images enhanced with gadopentetate dimeglumine. Semelka RC; Shoenut JP; Lawrence PH; Greenberg HM; Madden TP; Kroeker MA Radiology; 1992 Nov; 185(2):479-82. PubMed ID: 1410358 [TBL] [Abstract][Full Text] [Related]
24. Optimization of magnetic resonance imaging parameters for left ventricular wall motion studies at 0.5 T. Pennell DJ; Manzara CC; Underwood SR; Longmore DB Br J Radiol; 1998 Oct; 71(850):1033-9. PubMed ID: 10211063 [TBL] [Abstract][Full Text] [Related]
25. Breast lesion detection and characterization at contrast-enhanced MR mammography: gadobenate dimeglumine versus gadopentetate dimeglumine. Pediconi F; Catalano C; Occhiato R; Venditti F; Fraioli F; Napoli A; Kirchin MA; Passariello R Radiology; 2005 Oct; 237(1):45-56. PubMed ID: 16126926 [TBL] [Abstract][Full Text] [Related]
26. Dynamic contrast-enhanced magnetic resonance imaging evaluation of VX2 carcinoma in a rabbit model: comparison of 1.0-M gadobutrol and 0.5-M gadopentetate dimeglumine. Chang JM; Moon WK; Cha JH; Jung EJ; Cho N; Kim SJ Invest Radiol; 2010 Oct; 45(10):655-61. PubMed ID: 20808238 [TBL] [Abstract][Full Text] [Related]
27. Effect of the rate of gadopentetate dimeglumine administration on abdominal vascular and soft-tissue MR imaging enhancement patterns. Strouse PJ; Prince MR; Chenevert TL Radiology; 1996 Dec; 201(3):809-16. PubMed ID: 8939236 [TBL] [Abstract][Full Text] [Related]
28. Dual effects of gadodiamide injection in depiction of the region of myocardial ischemia. Saeed M; Wendland MF; Yu KK; Li HT; Higgins CB J Magn Reson Imaging; 1993; 3(1):21-9. PubMed ID: 8428089 [TBL] [Abstract][Full Text] [Related]
29. Dentate Nucleus Signal Intensity Decrease on T1-weighted MR Images after Switching from Gadopentetate Dimeglumine to Gadobutrol. Behzadi AH; Farooq Z; Zhao Y; Shih G; Prince MR Radiology; 2018 Jun; 287(3):816-823. PubMed ID: 29533723 [TBL] [Abstract][Full Text] [Related]
30. Chronic pancreatitis: MR imaging features before and after administration of gadopentetate dimeglumine. Semelka RC; Shoenut JP; Kroeker MA; Micflikier AB J Magn Reson Imaging; 1993; 3(1):79-82. PubMed ID: 8428105 [TBL] [Abstract][Full Text] [Related]
31. Gadopentetate dimeglumine-enhanced MR imaging of the postoperative lumbar spine: comparison of fat-suppressed and conventional T1-weighted images. Mirowitz SA; Shady KL AJR Am J Roentgenol; 1992 Aug; 159(2):385-9. PubMed ID: 1632362 [TBL] [Abstract][Full Text] [Related]
32. Tumor imaging with a macromolecular paramagnetic contrast agent: gadopentetate dimeglumine-polylysine. Opsahl LR; Uzgiris EE; Vera DR Acad Radiol; 1995 Sep; 2(9):762-7. PubMed ID: 9419637 [TBL] [Abstract][Full Text] [Related]
33. T1 contrast in the myocardium and blood pool: a quantitative assessment of gadopentetate dimeglumine and gadofosveset trisodium at 1.5 and 3 T. Lin K; Lloyd-Jones DM; Spottiswoode B; Bi X; Liu Y; Lu B; Xue H; Wang Y; Li D; Carr JC Invest Radiol; 2014 Apr; 49(4):243-8. PubMed ID: 24473364 [TBL] [Abstract][Full Text] [Related]
34. Dynamic MRI of a hypovascularized liver tumor model: comparison of a new blood pool contrast agent (24-gadolinium-DTPA-cascade-polymer) with gadopentetate dimeglumine. Tacke J; Adam G; Classen H; Mühler A; Prescher A; Günther RW J Magn Reson Imaging; 1997; 7(4):678-82. PubMed ID: 9243388 [TBL] [Abstract][Full Text] [Related]
36. Acute hemodynamic effects of recently developed monomer and dimer magnetic resonance imaging contrast media: a comparative study. Geschwind JF; Saeed M; Wendland MF; Szolar D; Derugin N; Higgins CB Acad Radiol; 1996 Aug; 3(8):667-77. PubMed ID: 8796731 [TBL] [Abstract][Full Text] [Related]
37. [Evaluating signal intensity of movement-impaired myocardial segments in MR delayed images after administration of Gd-DTPA. Correlation of regional increase in contraction after revascularization]. Sandstede J; Lipke C; Beer M; Kenn W; Pabst T; Neubauer S; Hahn D Radiologe; 2000 Feb; 40(2):150-4. PubMed ID: 10758629 [TBL] [Abstract][Full Text] [Related]
38. Intraindividual comparison of T1 relaxation times after gadobutrol and Gd-DTPA administration for cardiac late enhancement imaging. Doeblin P; Schilling R; Wagner M; Luhur R; Huppertz A; Hamm B; Taupitz M; Durmus T Eur J Radiol; 2014 Apr; 83(4):660-4. PubMed ID: 24433640 [TBL] [Abstract][Full Text] [Related]
39. Detecting pulmonary abnormalities on magnetic resonance images in patients with usual interstitial pneumonitis: effect of varying window settings and gadopentetate dimeglumine. King MA; Bergin CJ; Ghadishah E; Yi ES; Clark JB Acad Radiol; 1996 Apr; 3(4):300-7. PubMed ID: 8796678 [TBL] [Abstract][Full Text] [Related]
40. The role of fat-suppression technique and gadopentetate dimeglumine in magnetic resonance imaging evaluation of intraocular tumors and simulating lesions. De Potter P; Flanders AE; Shields JA; Shields CL; Gonzales CF; Rao VM Arch Ophthalmol; 1994 Mar; 112(3):340-8. PubMed ID: 8129659 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]